BRANDES INVESTMENT PARTNERS, LP 13D/13G Filings for Avadel Pharmaceuticals plc (AVDL)

BRANDES INVESTMENT PARTNERS, LP 13D and 13G filings for Avadel Pharmaceuticals plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-14
1:14 pm
Purchase
2025-03-31 13G Avadel Pharmaceuticals plc
AVDL
BRANDES INVESTMENT PARTNERS, LP 5,670,682
5.900%
5,670,682increase
(New Position)
Filing